This product is a prescription medication that combines two active ingredients: saxagliptin (5 mg) and metformin hydrochloride (500 mg). It is primarily used to improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise.

Benefits:
-Helps lower blood sugar levels by increasing insulin production and decreasing glucose production in the liver.
-The combination of saxagliptin and metformin can lead to better glycemic control compared to either medication alone.
-May aid in weight management as metformin is associated with weight neutrality or modest weight loss.
-Can reduce the risk of diabetes-related complications when used as part of a comprehensive treatment plan.

Precautions:
-Not suitable for individuals with a history of severe kidney problems, metabolic acidosis, or hypersensitivity to any component of the drug.
-Caution is advised for patients with liver disease, heart failure, or those who consume excessive alcohol.
-Regular monitoring of kidney function is recommended during treatment.
-Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Side Effects:
-Common side effects include gastrointestinal issues such as nausea, vomiting, diarrhea, abdominal pain, and flatulence.
-Serious side effects may include lactic acidosis (a rare but serious condition), pancreatitis, and allergic reactions.
-Patients should seek immediate medical attention if they experience symptoms like muscle pain, difficulty breathing, or unusual tiredness.

Main Ingredients and Their Benefits:
-Saxagliptin is a DPP-4 inhibitor that helps to lower blood sugar levels by increasing the levels of incretin hormones, which in turn increases insulin secretion and decreases glucagon secretion in response to meals.
-Metformin is an oral antihyperglycemic agent that primarily works by decreasing hepatic glucose production, improving insulin sensitivity, and enhancing peripheral glucose uptake and utilization, thus effectively lowering blood sugar levels.